Stay updated on Atezolizumab and Epacadostat Combination Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.

Latest updates to the Atezolizumab and Epacadostat Combination Clinical Trial page
- CheckyesterdayChange DetectedThe website’s revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe NIH transition announcement banner was removed from the top of the page; the 403 error and the rest of the page remain.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page. The former 403 error message and its Home link are no longer displayed.SummaryDifference2%

- Check36 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2 on the forbidden-access page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab and Epacadostat Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.